Overview

Gender

female

Leah Frye (Ph.D.) is the Vice President, Drug Discovery Applications Group at Schrodinger.

Leah Frye, Vice President of the Drug Discovery Applications Group, joined Schrödinger in 2001.

She received her Ph.D. in Synthetic Organic Chemistry from The Johns Hopkins University in 1984, and was an NIH NRSA Postdoctoral Fellow in the Department of Pharmacology and Experimental Therapeutics at The Johns Hopkins School of Medicine.

Before joining Schrödinger, Leah was a Principal Scientist at Boehringer Ingelheim Pharmaceuticals and prior to that she was an Associate Professor of Chemistry at Rensselaer Polytechnic Institute.